Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces $525 Million Accretive Core-Area Saskatchewan Asset Acquisition (click to learn more) Safe Supply Streaming Portfolio Company Safety Strips, Provides Corporate Update (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Palatin Technologies Inc PTN

Healthcare Biotechnology
Palatin Technologies, Inc. is a biopharmaceutical company. The Company is engaged in developing medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with unmet medical need and commercial potential. Its new product development activities focus primarily on MC1r agonists... see more

Recent & Breaking News (NYSEAM:PTN)

Palatin To Report Fourth Quarter And Fiscal Year End 2021 Results; Teleconference And Webcast To Be Held On September 29, 2021

PR Newswire September 24, 2021

Palatin to Present Peptides Platform at the TIDES USA Conference

PR Newswire September 15, 2021

Palatin to Participate in H.C. Wainwright 23rd Annual Global Investment Virtual Conference

PR Newswire September 13, 2021

Palatin Announces Presentation at the Eyecelerator@ASCRS Conference

PR Newswire July 22, 2021

Palatin Announces Adjournment of Annual Meeting of Stockholders

PR Newswire July 8, 2021

Palatin Announces Positive End-of-Phase 2 Meeting with FDA on PL9643 for the Treatment of Dry Eye Disease

PR Newswire June 29, 2021

Palatin Announces New Additions to Its Senior Leadership Team

PR Newswire June 28, 2021

Palatin Announces Adjournment of Annual Meeting of Stockholders

PR Newswire June 10, 2021

Palatin Reports Financial Results for the Third Fiscal Quarter of 2021 and Provides Corporate Update

PR Newswire May 17, 2021

Palatin Hosting Key Opinion Leader Webinar in Role of Melanocortin Agonists in Inflammation and the Treatment of Ocular Indications

PR Newswire May 14, 2021

Palatin to Report Third Quarter, Fiscal Year 2021 Results; Teleconference and Webcast to be held on May 17, 2021

PR Newswire May 13, 2021

Palatin Announces Two Presentations at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

PR Newswire April 20, 2021

Palatin Technologies to Participate in H.C. Wainwright Global Life Sciences Virtual Conference

PR Newswire March 5, 2021

Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2021 Financial Results and Recent Business Highlights

PR Newswire February 17, 2021

Palatin Technologies, Inc. to Report Second Quarter, Fiscal Year 2021 Results; Teleconference and Webcast to be held on February 17, 2021

PR Newswire February 12, 2021

Palatin Technologies Announces Filing of International Patent Application Claiming PL9643

PR Newswire February 10, 2021

Palatin Technologies Announces Positive Results From its Phase 2 Study of PL9643 in Patients With Dry Eye Disease

PR Newswire December 15, 2020

Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2021 Results and Provides Business Update

PR Newswire November 17, 2020

Palatin Technologies, Inc. to Report First Quarter, Fiscal Year 2021 Results; Teleconference and Webcast to be held on November 17, 2020

PR Newswire November 12, 2020

Palatin Technologies, Inc. Announces Fourth Quarter and Fiscal Year 2020 Financial Results and Provides a Business Update

PR Newswire September 28, 2020